Cost-effectiveness analysis: out of touch with clinical reality?

Arthritis Rheum. 2005 Feb 15;53(1):3-4. doi: 10.1002/art.20906.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antirheumatic Agents / economics*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / economics*
  • Cost-Benefit Analysis
  • Humans

Substances

  • Antirheumatic Agents